Loading...
Printed on 7/19/2026
For informational purposes only. This is not medical advice.
The Revised Cardiac Risk Index (RCRI, Lee criteria) estimates 30-day risk of major cardiac complications in patients undergoing non-cardiac surgery. It assigns one point for each of six predictors and stratifies patients into risk classes to support preoperative planning.
Formula: RCRI score = sum of 6 predictors (0-6). Class I: 0, Class II: 1, Class III: 2, Class IV: >=3.
Save your results with a free account
Keep a history of calculations, favorite tools, and access your dashboard anytime.
Systematically assess the patient for each of the six RCRI predictors: (1) Ischemic heart disease — defined as history of myocardial infarction, positive exercise stress test, current complaint of ischemic chest pain, use of nitrate therapy, or ECG with pathological Q waves. Do NOT include angina that has not been confirmed as ischemic. (2) Congestive heart failure — history of CHF, pulmonary edema, or paroxysmal nocturnal dyspnea; bilateral rales or S3 on current exam; or chest X-ray with pulmonary vascular redistribution. (3) Cerebrovascular disease — history of transient ischemic attack (TIA) or ischemic stroke at any time. (4) High-risk surgery — intraperitoneal, intrathoracic, OR suprainguinal vascular surgery. This is the most commonly missed criterion; note that lower extremity infrainguinal vascular surgery is NOT included. (5) Insulin-dependent diabetes mellitus — patients on insulin therapy regardless of DM type or duration. Oral hypoglycemics alone do NOT qualify. (6) Pre-operative serum creatinine greater than 2.0 mg/dL (177 µmol/L) — check the most recent pre-operative lab value.
Each qualifying factor earns exactly one point. Add all qualifying factors to produce the RCRI score, which ranges from 0 to 6. Most patients in clinical practice score 0, 1, or 2; scores of 4 or higher are uncommon. The RCRI classifies patients into four risk classes: Class I (0 factors), Class II (1 factor), Class III (2 factors), and Class IV (3 or more factors). Higher class corresponds to greater estimated risk of 30-day major adverse cardiac events (MACE), which include non-fatal myocardial infarction, non-fatal cardiac arrest, and cardiac death.
Translate the RCRI class into an estimated 30-day MACE risk based on the original Lee 1999 validation: Class I (0 factors): ~0.4–0.5% MACE; Class II (1 factor): ~0.9–1.3% MACE; Class III (2 factors): ~3.6–6.6% MACE; Class IV (≥3 factors): ~9–11%+ MACE. These percentages were derived from a general surgical population; vascular surgery patients have higher baseline risk. Use the estimated risk and the 2014 ACC/AHA Perioperative Guidelines decision framework: RCRI 0–1 with adequate functional capacity (≥4 METs) → proceed to surgery without additional cardiac testing. RCRI 2 → consider functional capacity assessment; if poor (<4 METs) and findings would change management, consider pharmacological stress testing or coronary evaluation. RCRI ≥3 → evaluate functional capacity; if poor, pharmacological stress testing or cardiology referral before elective surgery should be considered.
Anesthesiologists, perioperative medicine physicians, internists
The RCRI is the primary tool for estimating perioperative MACE risk in patients scheduled for non-cardiac surgery, as designated by the 2014 ACC/AHA Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery guidelines. Apply RCRI to every adult patient during the pre-anesthetic evaluation to estimate 30-day cardiac event risk and to structure shared decision-making about whether to proceed with elective surgery, delay for optimization, or refer for cardiology evaluation.
Perioperative clinicians, cardiologists, internists
The RCRI guides decisions about whether additional cardiac testing (echocardiography, nuclear stress test, dobutamine stress echocardiography, or coronary angiography) is needed before non-cardiac surgery. Per ACC/AHA 2014 guidelines, RCRI 0–1 combined with adequate functional capacity (≥4 METs — ability to climb a flight of stairs or walk up a hill without symptoms) does not require additional testing. RCRI ≥2 with poor functional capacity may indicate stress testing if findings would change perioperative management. Avoid reflexive pre-operative stress testing that does not change management, as this is a recognized overuse pattern.
Cardiologists, hospitalists, surgeons
RCRI score informs perioperative beta-blocker management based on POISE and related evidence. Patients already on beta-blockers should continue them perioperatively regardless of RCRI. New beta-blocker initiation is appropriate only in specific high-risk patients (RCRI ≥3 or those undergoing high-risk vascular surgery with clinical ischemia on stress testing) — do NOT initiate beta-blockers de novo in patients with RCRI <3, as the POISE trial showed harm from new perioperative beta-blockade in lower-risk patients. Statins should be continued perioperatively in all patients already taking them.
Vascular surgeons, vascular anesthesiologists
While RCRI was developed in a general surgical population and may underestimate cardiac risk in vascular surgery patients, it provides useful baseline risk stratification in this high-risk group. Most patients undergoing major vascular surgery (abdominal aortic, infrainguinal bypass, carotid endarterectomy) have at least one or two RCRI factors, placing them in Class III or IV. Complement RCRI with NSQIP vascular-specific tools and cardiac biomarkers (BNP/NT-proBNP) in high-risk vascular cases per 2014 ACC/AHA guidance.
Surgeons, anesthesiologists, perioperative medicine clinicians
Use RCRI to frame risk communication with patients considering non-cardiac surgery. Translating RCRI class into plain-language risk percentages supports informed consent discussions: 'With your heart condition, diabetes, and kidney disease, your estimated risk of a serious cardiac event (heart attack or cardiac arrest) from this surgery is about 9–11 in 100. Let's discuss whether the surgical benefit justifies this risk and whether we can optimize your health first.' This empowers patients to participate in shared decision-making.
The RCRI defines high-risk surgery as intraperitoneal, intrathoracic, OR suprainguinal vascular surgery only. Many clinicians incorrectly include all 'major' surgeries in this category. Notably excluded: infrainguinal lower extremity vascular (femoral-popliteal bypass), all orthopedic surgery including joint replacement, head and neck surgery, and superficial procedures. Inclusion of non-qualifying surgeries inflates the RCRI score and leads to unnecessary cardiac workup.
The 2014 ACC/AHA guidelines are clear: patients with RCRI 0–1 who can perform at least 4 METs of activity (climb one flight of stairs, walk on level ground at 4 mph, do light housework) without symptoms do NOT require additional cardiac workup before elective non-cardiac surgery. Ordering stress tests in this group is a recognized overuse pattern that delays care without improving outcomes. Confirm functional capacity with the Duke Activity Status Index (DASI) questionnaire or direct questioning.
High RCRI does not automatically mandate stress testing. The ACC/AHA stepwise algorithm first assesses functional capacity — if the patient can perform ≥4 METs, surgery can proceed. Stress testing is considered only when functional capacity is unknown or poor AND the result would change management. Ask: 'If the stress test is positive, will we delay surgery, pursue revascularization, or prescribe beta-blockers?' If the answer is no, the test should not be ordered.
For patients with RCRI ≥2 or other high-risk features, pre-operative BNP or NT-proBNP provides additional independent prognostic information about 30-day and long-term MACE, as supported by ACC/AHA 2014 (Class IIb recommendation). BNP >92 pg/mL or NT-proBNP >300 pg/mL pre-operatively is associated with significantly increased perioperative cardiac events. This may prompt additional cardiac evaluation or heightened perioperative monitoring.
The POISE trial demonstrated that newly starting metoprolol succinate before non-cardiac surgery reduced non-fatal MI but significantly increased stroke risk and overall mortality in the unselected population. Current ACC/AHA guidance reserves new perioperative beta-blocker initiation for patients with RCRI ≥3 (or scheduled for high-risk vascular surgery with ischemia on stress testing), and only when started more than 1 day before surgery at low doses with titration. Never initiate beta-blockers on the day of surgery.
Validation studies show RCRI may underestimate MACE risk in patients undergoing vascular surgery, where event rates are higher than in the general surgical population. The Vascular Study Group of New England tool and the NSQIP-based Myocardial Infarction and Cardiac Arrest (MICA) calculator were developed to better predict cardiac risk specifically in vascular procedures. Use RCRI as the starting point, but supplement with vascular-specific tools for abdominal aortic aneurysm repair, major bypass surgery, and carotid endarterectomy.
Patients with prior drug-eluting coronary stents who are on dual antiplatelet therapy (aspirin + P2Y12 inhibitor) require careful perioperative antiplatelet management. Per ACC/AHA and ASRA guidelines, elective non-cardiac surgery should ideally be delayed at least 12 months after DES placement. If surgery cannot be delayed, aspirin should generally be continued throughout the perioperative period unless the surgical bleeding risk is extreme (intracranial, spinal, intraocular). Stopping both antiplatelet agents risks catastrophic in-stent thrombosis. Always consult cardiology before altering antiplatelet therapy in stent patients.
Superficial surgery, cataract surgery, endoscopy, breast biopsy, and similar low-risk procedures have MACE rates of less than 1% even in high-RCRI patients. The ACC/AHA guidelines designate these procedures as 'low risk' and recommend proceeding without additional cardiac evaluation regardless of RCRI score. Applying RCRI-driven cardiac workup to low-risk surgical procedures is unnecessary and a common source of care delays.
Current ACC/AHA guidelines recommend measuring high-sensitivity troponin at 24 and 48 hours post-operatively in patients undergoing elevated-risk noncardiac surgery (Class IIa). Perioperative myocardial injury (PMI) — defined as any troponin elevation post-operatively — is 10× more common than clinically overt MI and carries a significant 30-day mortality signal. In patients with RCRI ≥2, routinely check hs-troponin post-operatively even in the absence of symptoms.
RCRI was developed by Lee et al. (Circulation 1999) from 4315 patients undergoing major non-cardiac surgery. MACE rates were 0.5%, 1.3%, 3.6%, and 9.1% for 0, 1, 2, and ≥3 factors respectively. Validated in multiple surgical cohorts worldwide. The 2014 ACC/AHA Perioperative Guidelines (Fleisher et al., JACC 2014) designated RCRI as the primary risk stratification tool for non-cardiac surgery. The POISE trial (Devereaux et al., Lancet 2008) informed beta-blocker guidance. Studies show RCRI may underestimate risk in vascular surgery; the Vascular Surgery Group of New England and NSQIP MICA tools were developed to address this limitation.
Higher RCRI scores indicate greater short-term risk of perioperative major cardiac complications after non-cardiac surgery.
Use RCRI during preoperative assessment for adult patients undergoing non-cardiac surgery when estimating perioperative cardiac event risk.
RCRI does not include all modern perioperative factors and may underperform in certain high-complexity populations. It should be combined with guideline-based evaluation and clinician judgment.
For related assessments, see ASA Class, Duke Treadmill Score and ASCVD Risk Calculator.
Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.
April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.
Classify preoperative physical status using the ASA I–VI system for anesthetic risk stratification. ASA III+ indicates significant systemic disease requiring special perioperative planning and precautions.
OpenCardiologyCalculate the Duke Treadmill Score for cardiac risk stratification from exercise stress testing. Uses exercise time, ST deviation, and angina symptoms.
OpenCardiologyCalculate 10-year ASCVD risk using current 2026 ACC/AHA Pooled Cohort Equations. Statin thresholds: <5% low, 5–7.5% borderline, ≥7.5% intermediate, ≥20% high.
OpenClinicalCalculate eGFR with the CKD-EPI 2021 race-free formula to estimate kidney function and CKD stage from serum creatinine, age, and sex.
Open